Table 5

Surrogate subtyping by 3-marker scoring
Luminal A Luminal B HER2-E Basal-like
ER+/PR+/HER2- (n = 471) 244 (52%) 170 (36%) 53 (11%) 4 (1%)
ESR1+/PGR+/ERBB2- (n = 397) 239 (60%) 127 (32%) 31 (8%) 0 (0%)
ER+/PR-/HER2- (n = 81) 12 (15%) 47 (58%) 19 (23%) 3 (4%)
ESR1+/PGR-/ERBB2- (n = 101) 15 (15%) 65 (64%) 18 (18%) 3 (3%)
ER-/PR-/HER2+ (n = 39) 0 (0%) 7 (18%) 30 (77%) 2 (5%)
ESR1-/PGR-/ERBB2+ (n = 51) 0 (0%) 6 (12%) 41 (80%) 4 (8%)
ER-/PR-/HER2- (n = 101) 4 (4%) 10 (10%) 30 (30%) 57 (56%)
ESR1-/PGR-/ERBB2- (n = 90) 0 (0%) 2 (2%) 28 (31%) 60 (67%)
ER+/PR+/HER2+ (n = 45) 2 (4%) 18 (40%) 25 (56%) 0 (0%)
ESR1+/PGR+/ERBB2+ (n = 80) 23 (29%) 33 (41%) 24 (30% 0 (0%)
ER+/PR-/HER2+ (n = 18) 0 (0%) 4 (22%) 14 (78%) 0 (0%)
ESR1+/PGR-/ERBB2+ (n = 53) 0 (0%) 28 (53%) 25 (47%) 0 (0%)
ER-/PR+/HER2- (n = 25) 14 (56%) 4 (16%) 3 (12%) 4 (16%)
ESR1-/PGR+/ERBB2- (n = 7) 0 (0%) 0 (0%) 4 (57%) 3 (43%)
ER-/PR+/HER2+ (n = 2) 1 (50%) 1 (50%) 0 (0%) 0 (0%)
ESR1-/PGR+/ERBB2+ (n = 3) 0 (0%) 0 (0%) 3 (100%) 0 (0%)

Bastien et al.

Bastien et al. BMC Medical Genomics 2012 5:44   doi:10.1186/1755-8794-5-44

Open Data